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Aim To analyze melanoma incidence and mortality trends 
in Croatia 1988-2008, compare them with the trends in 
other populations, and identify possible changes in the 
trends.
Methods Incidence data were obtained from the Croatian 
National Cancer Registry and the mortality data from the 
Croatian Bureau of Statistics. United Nations population 
estimates were used for calculating the age-specific rates. 
Age-standardized rates were calculated by the direct stan-
dardization method, using the world standard population 
as a reference. To estimate incidence and mortality trends, 
we performed joinpoint regression analysis.
Results  A  significantly  increasing  incidence  trend,  with 
estimated annual percent change (EAPC) of 5.9% for men 
and 5.6% for women, was observed over the whole 21-year 
period and no additional joinpoints were identified. The 
overall incidence increase between the first and the last 
five-year period was 149% for men and 130% for women. 
Significant increase in the mortality trend was observed, 
with EAPC of 3.0% for men and 2.4% for women. No join-
points were identified. The overall increase in mortality be-
tween the first and the last five-year period was 45% for 
men and 50% for women.
Conclusion Melanoma rates in Croatia are steadily and 
markedly rising, with similar trends to those in the coun-
tries with lower/intermediate incidence. It is important to 
further investigate the more specific causes of the increas-
ing trends, as well as to implement effective public policies 
targeting the melanoma burden.
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Malignant melanoma of the skin is a cancer originating in 
melanocytes, the pigment-producing cells of the skin (1). 
Unlike basal and squamous cell cancers of the skin that are 
rarely fatal, its five-year relative survival in Europe is 83.1% 
(2). With 286 new cases and 118 yearly deaths in men and 
275 new cases and 79 deaths in women in Croatia in 2008, 
melanoma represented 2.6% of male cancer incidence and 
1.1% of cancer deaths in men, and 2.9% of female cancer in-
cidence and 1.4% of cancer deaths in women (3).
The strongest environmental risk factor for malignant mela-
noma in white populations is exposure to UV light (4). In-
termittent sun exposure, especially before the age of 10 is 
considered to be a stronger risk factor than a continuous ex-
posure (5,6). Other risk factors for malignant melanoma in-
clude invasive melanoma of the skin in one or more first de-
gree-relatives, history of primary invasive melanoma, more 
than a hundred banal melanocytic nevi, three or more clini-
cally atypical (dysplastic) nevi, pale Caucasian skin (type 1 or 
2), red or blond hair, history of one or more severe blistering 
sunburns, sunbed use (especially before the age of 30), and 
history of pesticide exposure (6).
Generally, melanoma incidence rates in Caucasian popula-
tions increase with proximity to the Equator (7). However, 
there are variations across Europe, with Switzerland, Den-
mark,  Norway,  Sweden,  and  the  Netherlands  having  the 
highest rates (15-18/100 000 in men and 16-22/100 000 in 
women) and Central and Southeastern Europe countries 
the lowest (4.4/100 000 for men and 4.3/100 000 for wom-
en) (8). Until now, recent trends in melanoma incidence and 
mortality have been less studied in the Mediterranean and 
Eastern European populations. The aim of this study was to 
analyze the melanoma incidence and mortality trends in 
Croatia 1988-2008, compare them with the trends in other 
populations, and identify possible changes.
MAteriAls And Methods
data sources
Incidence data for the period 1988-2008 were obtained 
from the Croatian National Cancer Registry. The Registry, 
founded in 1959, covers the whole Croatian population 
(approximately  4.4  million  persons)  and  relies  on  man-
datory cancer notifications from primary and secondary 
health care sources and death certificates from the Croa-
tian Bureau of Statistics. The Registry contributed data to 
the last three volumes of the Cancer Incidence in Five 
Continents series (9-11). Melanoma was defined as 
ICD-9 code 172 and ICD-10 code C43 (12). The number of 
melanoma deaths was obtained from the WHO Mortality 
Database (13). For calculating age-specific rates, we used 
the UN population estimates (14).
statistical analysis
Age-standardized rates of melanoma incidence in Croatia 
were calculated by the direct standardization method, us-
ing the world standard population as a reference (15). To 
describe incidence and mortality trends by calendar period, 
we carried out joinpoint regression analysis using the Join-
point Regression Software (16). The aim of the approach is 
to identify possible joinpoints where a significant change in 
the log-linear trend occurs. To obtain the estimated annual 
percent change (EAPC), a regression line was fitted to the 
natural logarithm of the rates using calendar year as the re-
sponse (17). In describing trends, the terms “significant in-
crease” or “significant decrease” signify that the slope of the 
trend was statistically significant (P < 0.05). For non-statisti-
cally significant trends (P > 0.05), we used the terms “stable” 
(EAPC between -0.5% and 0.5%), “non-statistically significant 
increase” (EAPC>0.5%), and “non-statistically significant de-
crease” (EAPC<-0.5%). All statistical tests were two sided.
results
From 1988 to 2008, there were 3517 male and 3590 fe-
male melanoma cases. The number of new cases ranged 
from 81 to 303 annually for men, and from 87 to 284 for 
women (Table 1, 2). The significantly increasing incidence 
trend, with EAPC of 5.9% (95% confidence interval [CI], 4.5 
Figure 1. Joinpoint analysis for incidence and mortality of melanoma in 
Croatian men, 1988-2008. rhombs – incidence; triangles – mortality; Asr   
(W)– age-standardized rate per 100 000 (using world standard population).137 Barbarić and Znaor: Melanoma trends in Croatia
www.cmj.hr
to 7.5) for men and 5.6% for women (95% CI, 4.3 to 6.9) 
was observed over the whole 21-year period and no ad-
ditional joinpoints were identified (Figure 1, 2). The overall 
incidence increase between the first and the last five-year 
period was 149% for men and 130% for women (Table 3). 
There were 1568 men and 1323 women who died of mel-
anoma. The number of annual melanoma deaths ranged 
between 38 and 118 for men and between 39 and 94 for 
women (Tables 1, 2). Mortality trend showed a significant 
increase, with EAPC of 3.0% for men and 2.4% for wom-
en (95% CI, 1.6% to 4.4% and 1.3% to 3.6% respectively). 
No joinpoints were identified (Figures 1, 2). The overall in-
crease in mortality between the first and the last five-year 
period was 45% for men and 50% for women (Table 3).
disCussion
This study was the first to systematically analyze melano-
ma incidence and mortality trends in the Croatian popu-
lation. Compared to other European countries from the 
GLOBOCAN  2008  database,  Croatia  had  an  intermedi-
ate melanoma incidence, with the ASR of 8.7/100 000 for 
men and 7.0/100 000 for women. However, with the ASR 
of 3.5/100 000 for men and 1.8/100 000 for women, it had 
the third highest male and fourth highest female mortal-
ity rate in Europe (8). As opposed to the majority of Euro-
pean countries, which had a higher incidence in women, 
Croatia had a higher incidence in men, similar to Australia 
tABle 1. incidence and mortality of melanoma in Croatian 
men, 1988-2008
incidence Mortality
Year n crude rate Asr(W)* n crude rate Asr(W)
1988   81   3.7 3.1   51 2.4 1.9
1989   81   3.7 3.0   50 2.3 1.8
1990   88   4.0 3.3   38 1.7 1.4
1991   86   3.9 3.1   55 2.5 2.1
1992   91   4.1 3.2   60 2.7 2.1
1993 114   5.1 3.8   66 3.0 2.1
1994   97   4.3 3.2   67 3.0 2.2
1995 143   6.4 4.7   38 1.7 1.2
1996 122   5.4 4.0   61 2.7 2.0
1997 127   5.7 4.0   70 3.1 2.1
1998 140   6.3 4.5   84 3.8 2.7
1999 207   9.5 6.8   86 3.9 2.8
2000 240 11.1 7.6   91 4.2 2.9
2001 234 10.8 7.6 106 4.9 3.3
2002 194   9.0 6.2   71 3.3 2.3
2003 198   9.2 6.2   96 4.5 2.9
2004 191   8.9 6.1   92 4.3 2.9
2005 303 14.2 9.4   98 4.6 2.9
2006 239 11.2 7.2   73 3.4 2.2
2007 254 11.9 7.7   97 4.6 2.8
2008 287 13.5 8.7 118 5.6 3.5
*Asr(W) – age-standardized rates (using standard world population).
tABle 2. incidence and mortality of melanoma in Croatian 
women, 1988-2008
incidence Mortality
Year n crude rate Asr(W) n crude rate Asr(W)
1988   87   3.8 2.5 53 2.3 1.4
1989   93   4.0 2.8 44 1.9 1.2
1990 106   4.6 3.0 50 2.1 1.4
1991 108   4.6 3.3 58 2.5 1.5
1992 100   4.2 2.9 39 1.6 1.0
1993 108   4.5 3.2 43 1.8 1.1
1994 102   4.2 2.8 45 1.9 1.2
1995 152   6.3 4.3 62 2.6 1.5
1996 106   4.4 3.0 44 1.8 1.2
1997 133   5.6 3.8 59 2.5 1.5
1998 119   5.0 3.4 65 2.7 1.7
1999 214   9.1 5.6 54 2.3 1.2
2000 218   9.3 6.0 65 2.8 1.5
2001 236 10.2 6.5 78 3.4 1.9
2002 212   9.2 6.0 71 3.1 1.8
2003 219   9.5 5.4 65 2.8 1.4
2004 238 10.3 6.4 94 4.1 2.3
2005 284 12.3 7.5 94 4.1 2.0
2006 235 10.2 5.8 81 3.5 1.9
2007 246 10.7 6.4 80 3.5 1.7
2008 274 12.0 7.0 79 3.5 1.8
*Asr(W) – age-standardized rates (using standard world population).
Figure 2. Joinpoint analysis for incidence and mortality of melanoma in 
Croatian women, 1988-2008. rhombs – incidence; triangles – mortality; Asr   
(W)– age-standardized rate per 100 000 (using world standard population).CANCER EPIDEMIOLOGY  138 Croat Med J. 2012;53:135-40
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and North America (8). Croatia also had a higher mortality 
rate in men.
Since the 1970s, melanoma incidence rates in populations 
of European origin doubled every 10 to 20 years (18). In 
Northern Europe, they became very high during the 1980s 
but have been leveling off since the mid-1990s (18,19). In 
Southern and Eastern Europe, on the other hand, the rates 
are still increasing (18,20-22). Mortality rates are leveling 
off in many populations with high incidence rates (such as 
Australia, USA, Scandinavian countries, the UK) (18,23-27), 
but are still increasing in most of Eastern and Southern Eu-
ropean populations (18,21,22,27). Our results are similar to 
those in the countries with lower/intermediate incidence, 
eg, Italy with EAPC of 5.2% for men and 5.3% for women in 
the period 1985-2003 (22).
Croatian coast and islands have more than 2600 hours of 
sunshine per year, which contributes to intensive periodi-
cal sun exposure of the population (28). Since intermittent 
sun exposure is a major risk factor, the observed increas-
es in Croatia may be attributed to popularization of tour-
ism and holidaymaking in the 1950s and 1960s and the 
consumer practices of the 1970s and 1980s (29). In most 
countries, mortality rates have not increased as rapidly as 
incidence rates and it is controversial whether the increase 
in incidence is actually a consequence of increased sur-
veillance and better detection of thin, minimally invasive 
melanomas (30). Due to the lack of information on stage 
and thickness of the tumors, it is impossible to determine 
whether increased awareness and early detection contrib-
uted to the increasing incidence trends in Croatia.
There has been only a modest progress in the manage-
ment of advanced disease, and early diagnosis remains 
crucial in improving the survival (31,32). There are 
prevention and early detection strategies available, which 
have been developed and used in countries with higher 
incidence rates, including ABCDE guidelines and Glasgow 
7-point checklist (33,34). Helping general public in recog-
nizing melanomas and having them removed at an early 
stage was first done in the Queensland Melanoma Project 
(35), and then reproduced in the US and some European 
countries, such as the UK, resulting in earlier diagnosis and 
increase in the proportion of patients with thinner mela-
nomas  and  better  prognosis  (34,36,37).  Several  popula-
tion-based case-control studies suggest that whole body 
skin self-examination, as well as examination by clinicians, 
reduces  the  risk  of  thick  melanomas  (38,39).  However, 
there are currently no completed randomized control tri-
als that would confirm this. A randomized-controlled trial 
of a community-based melanoma screening program in 
Queensland, Australia, is expected to be complete in 2015 
(34,40,41). A recent study in northern Germany has report-
ed promising results in terms of feasibility and effective-
ness of a systematic, two-step skin cancer screening pro-
gram for a population of 1.88 million (42).
Croatia participates in Euromelanoma, pan-European pre-
vention campaign against skin cancer that started in Bel-
gium in 1999 (43-45). During Euromelanoma Week, the 
general public has an opportunity to have a free-of-charge 
dermatologist screening of the moles (46). It still remains 
to be seen whether this campaign will have an effect on 
the incidence and mortality trends in Croatia. Still, more 
effort should be put into increasing public awareness of 
melanoma and its prevention. Further research is needed 
to identify risk groups, their needs, and sun exposure-relat-
ed behaviors to tailor Croatian prevention campaigns. In-
tegration with the existing public-health activities should 
be considered, for example with the “Health Promoting 
Schools” project (45,46), to raise awareness of sun exposure 
tABle 3. Melanoma incidence and mortality in Croatia (1988-2002 and 2004-2008).
incidence Mortality
Period Person – years* cases† Asr(W)‡ absolute change (%) deaths§ Asr (W)‡ absolute change (%)
Men:
1988-1992 2.19   85 3.1 - 51 1.9 -
2004-2008 2.13 255 7.8 149 91 2.7 45
Women:
1988-1992 2.34 99 2.9 - 49 1.3 -
2004-2008 2.30 255 6.6 130 86 1.9 50
*Mean annual male population expressed in million person-years at risk.
†Mean annual number of new cases.
‡Age-standardized rate (using standard world population).
§Mean annual number of deaths.139 Barbarić and Znaor: Melanoma trends in Croatia
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risks and ways of protection among school children, their 
parents, and teachers.
Current high mortality rates clearly indicate a need to im-
prove the outcomes of Croatian melanoma patients. At 
present, there is a great variation in the way they are diag-
nosed, treated, and followed. Policy-makers should ensure 
that every patient is treated to the same standards. As in 
other European countries, population aging is expected to 
occur, resulting in estimated 319 new male and 288 female 
melanoma cases in 2030, as well as 146 melanoma deaths 
in men and 88 in women (8). Therefore, an increased de-
mand for melanoma-related medical services is expected, 
which will also require more detailed incidence and mor-
tality data to enable adequate planning. What remains to 
be investigated are patterns of service provision and utili-
zation, waiting times, survival patterns, as well as patient 
pathways, needs, and experiences.
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